Outlook Therapeutics Inc (OTLK)
8.51
-0.41
(-4.60%)
USD |
NASDAQ |
May 01, 16:00
8.51
0.00 (0.00%)
After-Hours: 16:34
Outlook Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2019 | -1.057 |
| June 30, 2019 | -8.41 |
| March 31, 2019 | -0.5362 |
| December 31, 2018 | -0.6434 |
| September 30, 2018 | -0.8629 |
| June 30, 2018 | -1.905 |
| March 31, 2018 | -1.136 |
| December 31, 2017 | -2.161 |
| September 30, 2017 | -0.5874 |
| Date | Value |
|---|---|
| June 30, 2017 | -0.5651 |
| March 31, 2017 | -0.4274 |
| December 31, 2016 | -0.4511 |
| September 30, 2016 | -1.437 |
| June 30, 2016 | 4.948 |
| March 31, 2016 | -0.6332 |
| December 31, 2015 | -1.134 |
| September 30, 2015 | -0.695 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-8.41
Minimum
Jun 2019
-1.057
Maximum
Sep 2019
-4.734
Average
-4.734
Median
Debt to Equity Ratio Benchmarks
| Cutera Inc | -2.620 |
| Actinium Pharmaceuticals Inc | 0.00 |
| GT Biopharma Inc | -- |
| Karyopharm Therapeutics Inc | -1.255 |
| Marinus Pharmaceuticals Inc | 4.353 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 21.68M |
| Total Liabilities (Quarterly) | 46.03M |
| Shareholders Equity (Quarterly) | -24.34M |